{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:carotid:hyperperfusion",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-05T12:56:56.000Z",
    "contributors": [
      "copilot",
      "quality-enhancement-agent"
    ],
    "status": "peer-reviewed",
    "reviewedBy": [],
    "confidence": 0.95,
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/carotid-disease",
    "type": "complication",
    "difficulty": "advanced",
    "importance": "critical",
    "isNativeDomain": true
  },
  "content": {
    "title": "Cerebral Hyperperfusion Syndrome",
    "description": "A potentially fatal complication following carotid revascularization characterized by unilateral headache, seizures, and intracerebral hemorrhage due to loss of cerebrovascular autoregulation.",
    "definition": "Cerebral hyperperfusion syndrome (CHS) occurs when cerebral blood flow increases excessively following carotid endarterectomy or stenting due to impaired autoregulation in a chronically hypoperfused brain. Without treatment, it can progress to fatal intracerebral hemorrhage.",
    "clinical_features": {
      "pathophysiology": [
        "Chronic hypoperfusion causes maximal vasodilation",
        "Autoregulation impaired in chronically ischemic brain",
        "Revascularization suddenly increases perfusion pressure",
        "Impaired vessels cannot constrict appropriately",
        "Results in hyperperfusion, edema, hemorrhage"
      ],
      "risk_factors": [
        "High-grade stenosis (>90%)",
        "Contralateral carotid occlusion",
        "Recent stroke in ipsilateral hemisphere",
        "Poor collateral circulation",
        "Postoperative hypertension"
      ],
      "clinical_presentation": [
        "Onset: 1-14 days post-procedure (usually 3-7 days)",
        "Unilateral frontal/temporal headache (ipsilateral)",
        "Confusion, focal deficits",
        "Seizures (often focal motor)",
        "Intracerebral hemorrhage (if severe)"
      ],
      "management": [
        "Strict blood pressure control (SBP 100-140)",
        "Avoid hypotension (can worsen ischemia)",
        "Antiseizure prophylaxis controversial",
        "ICU monitoring for high-risk patients",
        "Treat seizures aggressively"
      ]
    },
    "codes": {
      "snomed_ct": [
        "735340007"
      ],
      "icd_10": [
        "I97.820"
      ]
    },
    "relationships": {
      "skos:broader": [
        "vascular:cea:complications"
      ],
      "skos:related": [
        "vascular:cas:complications",
        "vascular:carotid:stenosis"
      ],
      "skos:narrower": []
    },
    "cross_domain_references": [],
    "pedagogy": {
      "learning_objectives": [
        "Explain hyperperfusion syndrome pathophysiology",
        "Identify high-risk patients",
        "Recognize clinical presentation",
        "Apply prevention and treatment strategies"
      ],
      "clinical_pearls": [
        "Unilateral headache after CEA = hyperperfusion until proven otherwise",
        "BP control is cornerstone of prevention and treatment",
        "High-grade stenosis + contralateral occlusion = highest risk",
        "Occurs 1-14 days post-procedure, peak at day 5-7",
        "Intracerebral hemorrhage carries 50%+ mortality"
      ],
      "board_yield": "HIGH"
    },
    "statement": "Cerebral Hyperperfusion Syndrome is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Carotid-Disease that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Cerebral Hyperperfusion Syndrome helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Cerebral Hyperperfusion Syndrome include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Cerebral Hyperperfusion Syndrome."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). Cerebral Hyperperfusion Syndrome. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "owl:sameAs": "http://dbpedia.org/resource/Cerebral_Hyperperfusion_Syndrome",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}